HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Primary prevention of coronary heart disease with aspirin].

Abstract
According to meta-analysis and the results of the two studies with the highest power, aspirin is effective in primary prevention of coronary heart disease. These beneficial effects, however, are at least partially out-weight by unwanted effects-such as intense gastrointestinal bleeding and hemorrhagic stroke. These side effects remain constant with increasing risk of coronary heart disease, whereas the protective effects increase. If an annual risk of coronary heart disease of < or =0.6% exists, aspirin is normally not indicated; for a risk of 0.7-1.4% the facts should be discussed with the patient. If a risk of > or =1.5% exists, aspirin should be given. Problems of aspirin therapy--such as "aspirin paradox" and "aspirin resistance"--have been documented for secondary prevention; they might, however, have likewise clinical implications in primary prevention.
AuthorsW Kübler, H Darius
JournalZeitschrift fur Kardiologie (Z Kardiol) Vol. 94 Suppl 3 Pg. III/66-73 ( 2005) ISSN: 0300-5860 [Print] Germany
Vernacular TitlePrimäre Prävention der koronaren Herzkrankheit mit Aspirin.
PMID16258795 (Publication Type: English Abstract, Journal Article, Meta-Analysis)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Aspirin (therapeutic use)
  • Clinical Trials as Topic
  • Comorbidity
  • Coronary Disease (mortality, prevention & control)
  • Gastrointestinal Hemorrhage (mortality)
  • Humans
  • Incidence
  • Primary Prevention (methods, statistics & numerical data)
  • Risk Assessment (methods)
  • Risk Factors
  • Stroke (mortality)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: